Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» drisapersen
drisapersen
FDA Closing In on November Expert Panel Date for BioMarin, Sarepta Drugs
TheStreet.com
Mon, 07/20/15 - 02:37 pm
FDA
Biomarin
advisory panels
eteplirsen
Sarepta Therapeutics
drisapersen
Duchenne Muscular Dystrophy
Why BioMarin’s New Drug Application is Good News for Sarepta Therapuetics
Fierce Pharma Marketing
Wed, 05/6/15 - 11:44 am
Biomarin
Sarepta Therapeutics
drisapersen
Duchenne Muscular Dystrophy
BioMarin CEO Sees Big Future For Prosensa Drug
Investors.com
Wed, 12/24/14 - 08:58 am
Biomarin
Prosensa
drisapersen
Duchenne Muscular Dystrophy
Prosensa heads to the FDA with its once-failed DMD treatment
Fierce Biotech
Fri, 10/10/14 - 11:41 am
Prosensa
FDA
Duchenne Muscular Dystrophy
drisapersen
Tuesday’s Top Biotech Stories: Vanda Pharmaceuticals, Prosensa, and Clovis Oncology
Motley Fool
Tue, 06/3/14 - 11:38 am
Vanda
Prosensa
Clovis Oncology
Hetlioz
CO-1686
drisapersen
Prosensa to Seek U.S. Approval for DMD Drug
TheStreet.com
Tue, 06/3/14 - 11:00 am
Duchenne Muscular Dystrophy
Prosensa
drisapersen
Prosensa jumps 30% after data from Phase 2 study of DMD drug
The Fly on the Wall
Tue, 03/18/14 - 09:01 am
Prosensa
Duchenne Muscular Dystrophy
drisapersen
Sarepta Therapeutics
GSK hands back failed muscular dystrophy drug to Prosensa
Yahoo/Reuters
Mon, 01/13/14 - 09:00 am
GSK
Prosensa
Duchenne Muscular Dystrophy
drisapersen
3 Biggest FDA Decisions of 2013
Motley Fool
Wed, 12/4/13 - 08:18 am
FDA
Sarepta Therapeutics
drisapersen
Iclusig
Ariad Pharmaceuticals
Vascepa
Amarin
This Slide Paints Grim Picture of Glaxo, Prosensa's DMD Drug
TheStreet.com
Mon, 10/7/13 - 08:57 am
GSK
Prosensa
Duchenne Muscular Dystrophy
drisapersen
Sarepta Therapeutics
eteplirsen
Phase III Trial Ruins Prosensa's Drisapersen, Sarepta Rallies Strongly
Seeking Alpha
Mon, 09/23/13 - 10:37 am
Prosensa
Sarepta Therapeutics
drisapersen
GSK
Duchenne Muscular Dystrophy
GSK, Prosensa muscular dystrophy drug misses study goal
Reuters
Fri, 09/20/13 - 09:36 am
GSK
Prosensa
drisapersen
Duchenne Muscular Dystrophy
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
Four Promising Biotech Stocks With Upcoming Catalysts
Minyanville
Thu, 08/22/13 - 10:05 am
GSK
Sarepta
Gilead
sofosbuvir
SGX203
SGX942
Soligenix
drisapersen
Sarepta shares jump after disappointing test for rival drug
Reuters
Fri, 08/16/13 - 10:33 am
Prosensa
drisapersen
Duchenne Muscular Dystrophy
GSK
Sarepta
eteplirsen
Is The DMD Market Becoming Too Crowded?
Motley Fool
Tue, 07/9/13 - 05:14 pm
Duchenne Muscular Dystrophy
Sarepta
eteplirsen
drisapersen
GSK
PTC Therapeutics
Prosensa harvests $78M as biotech IPOs continue to sizzle
Fierce Biotech
Fri, 06/28/13 - 12:28 pm
Prosensa
IPOs
drisapersen
Glaxo grabs coveted breakthrough drug status for muscular dystrophy drug
Fierce Biotech
Thu, 06/27/13 - 11:56 am
breakthrough therapies
GSK
drisapersen
Duchenne Muscular Dystrophy
Sarepta Fans: A Single Data Slide Raises Questions About Glaxo's DMD Drug
TheStreet.com
Fri, 04/12/13 - 01:28 pm
Sarepta
GSK
Duchenne Muscular Dystrophy
drisapersen
eteplirsen
Muscular Dystrophy Drug Succeeds, Sarepta Buyers Flood In
Seeking Alpha
Thu, 04/11/13 - 11:33 am
Duchenne Muscular Dystrophy
Sarepta
GSK
eteplirsen
drisapersen
Prosensa
Pages
« first
‹ previous
1
2
3
next ›
last »